Salicylamide
NERVOUS SYSTEM
Also known as: 2-carbamoylphenol, 2-hydroxybenzamide, salicylic acid amide
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Salicylamide is a drug catalogued in DrugCentral. Recorded indications include Backache, Fever, Headache disorder and Joint pain.
- Indications: Backache, Fever, Headache disorder, Joint pain and Pain.
- ATC code: N02BA05 (Salicylic acid and derivatives).
- Molecular formula: C7H7NO2; molecular weight 137.14 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (5)
- Backache
- Fever
- Headache disorder
- Joint pain
- Pain
Contraindications (86)
- Acute abdominal pain
- Acute erosive gastritis
- Acute exacerbation of asthma
- Acute nephropathy
- Agoraphobia
- Alcoholism
- Aluminum intoxication
- Anemia
- Anemia due to enzyme deficiency
- Angle-closure glaucoma
- Atrophic gastritis
- Benign intracranial hypertension
- Benign prostatic hyperplasia
- Bladder outflow obstruction
- Blood coagulation disorder
- Body fluid retention
- Bradycardia
- Breastfeeding (mother)
- Cardiovascular event risk
- Central nervous system depression
- Chronic diarrhea
- Chronic disease of respiratory system
- Chronic idiopathic constipation
- Chronic obstructive lung disease
- Conduction disorder of the heart
- Constipation
- Decreased respiratory function
- Dependent drug abuse
- Diabetes mellitus
- Disease of liver
- + 56 more
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| — | FDA | — | — |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
N02BA05 | NERVOUS SYSTEM › ANALGESICS › OTHER ANALGESICS AND ANTIPYRETICS › Salicylic acid and derivatives |
N02BA55 | NERVOUS SYSTEM › ANALGESICS › OTHER ANALGESICS AND ANTIPYRETICS › Salicylic acid and derivatives |
N02BA75 | NERVOUS SYSTEM › ANALGESICS › OTHER ANALGESICS AND ANTIPYRETICS › Salicylic acid and derivatives |
Reported adverse-event signals
Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.
| MedDRA term | LLR |
|---|---|
| Sedation complication | 356.0 |
| Creatinine renal clearance decreased | 348.2 |
| Blood calcium decreased | 300.9 |
| Renal function test abnormal | 287.6 |
| Creatinine renal clearance increased | 273.6 |
| Orthostatic hypotension | 259.7 |
| Sedation | 253.1 |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Salicylamide is on its molecule page.
| Molecular formula | C7H7NO2 |
|---|---|
| Molecular weight | 137.14 g/mol |
| CAS number | 65-45-2 |
| InChIKey | SKZKKFZAGNVIMN-UHFFFAOYSA-N |
| PubChem CID | 5147 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Salicylamide used for?
DrugCentral lists the following indications for Salicylamide: Backache, Fever, Headache disorder, Joint pain and Pain.
What is the chemical formula of Salicylamide?
Salicylamide has the molecular formula C7H7NO2 and a molecular weight of 137.14 g/mol.
Browse: all drugs starting with S · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 2415 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL27577 — compound record and bioactivity
- PubChem CID 5147 — chemical identifiers
- DrugBank DB08797 — drug record
- FDA UNII EM8BM710ZC — substance identity
- DailyMed: FDA labels for Salicylamide — current prescribing information (label search)
- FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.